These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17764855)

  • 21. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.
    Papaleo E; Unfer V; Baillargeon JP; De Santis L; Fusi F; Brigante C; Marelli G; Cino I; Redaelli A; Ferrari A
    Gynecol Endocrinol; 2007 Dec; 23(12):700-3. PubMed ID: 17952759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Fertil Steril; 2008 Mar; 89(3):505-22. PubMed ID: 18243179
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel method to demonstrate that pregnant women with polycystic ovary syndrome hyper-expose their fetus to androgens as a possible stepping stone for the developmental theory of PCOS. A pilot study.
    Homburg R; Gudi A; Shah A; M Layton A
    Reprod Biol Endocrinol; 2017 Aug; 15(1):61. PubMed ID: 28789693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Consensus on infertility treatment related to polycystic ovary syndrome.
    Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group
    Hum Reprod; 2008 Mar; 23(3):462-77. PubMed ID: 18308833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of maternal PCOS and PCOS-like phenotype on the offspring's health.
    Puttabyatappa M; Cardoso RC; Padmanabhan V
    Mol Cell Endocrinol; 2016 Nov; 435():29-39. PubMed ID: 26639019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does polycystic ovary syndrome start in childhood?
    Diamanti-Kandarakis E; Christakou C; Palioura E; Kandaraki E; Livadas S
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):904-11. PubMed ID: 18552753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The reproductive phenotype in polycystic ovary syndrome.
    Chang RJ
    Nat Clin Pract Endocrinol Metab; 2007 Oct; 3(10):688-95. PubMed ID: 17893687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polycystic ovary syndrome in adolescence.
    Blank SK; Helm KD; McCartney CR; Marshall JC
    Ann N Y Acad Sci; 2008; 1135():76-84. PubMed ID: 18574211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oocyte quality in adult polycystic ovary syndrome.
    Patel SS; Carr BR
    Semin Reprod Med; 2008 Mar; 26(2):196-203. PubMed ID: 18302111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.
    Rizzo M; Berneis K; Hersberger M; Pepe I; Di Fede G; Rini GB; Spinas GA; Carmina E
    Hum Reprod; 2009 Sep; 24(9):2286-92. PubMed ID: 19454589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acupuncture in polycystic ovary syndrome: current experimental and clinical evidence.
    Stener-Victorin E; Jedel E; Mannerås L
    J Neuroendocrinol; 2008 Mar; 20(3):290-8. PubMed ID: 18047551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index.
    McCormick B; Thomas M; Maxwell R; Williams D; Aubuchon M
    Fertil Steril; 2008 Dec; 90(6):2304-9. PubMed ID: 18191852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polycystic ovary syndrome and pregnancy outcome: red herring or red flag?
    Siassakos D; Wardle P
    BJOG; 2007 Aug; 114(8):922-32. PubMed ID: 17635486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights.
    Westerveld HE; Hoogendoorn M; de Jong AW; Goverde AJ; Fauser BC; Dallinga-Thie GM
    Pharmacol Ther; 2008 Sep; 119(3):223-41. PubMed ID: 18602948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal origins of the metabolic syndrome.
    Xita N; Tsatsoulis A
    Ann N Y Acad Sci; 2010 Sep; 1205():148-55. PubMed ID: 20840267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endocrine and metabolic differences among phenotypic expressions of polycystic ovary syndrome according to the 2003 Rotterdam consensus criteria.
    Kauffman RP; Baker TE; Baker VM; DiMarino P; Castracane VD
    Am J Obstet Gynecol; 2008 Jun; 198(6):670.e1-7; discussion 670.e7-10. PubMed ID: 18355776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of sex hormone-binding globulin and androgen receptor gene variants in the development of polycystic ovary syndrome.
    Xita N; Georgiou I; Lazaros L; Psofaki V; Kolios G; Tsatsoulis A
    Hum Reprod; 2008 Mar; 23(3):693-8. PubMed ID: 18192296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterizing cardiovascular risk in women with polycystic ovary syndrome: more than the sum of its parts?
    Chang AY; Wild RA
    Semin Reprod Med; 2009 Jul; 27(4):299-305. PubMed ID: 19530063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.